By Charles Grob — 1996
On November 26, 1996, Charles Grob, M.D. visited with Albert Hofmann in Rheinfelden, outside of Basel, Switzerland, where Dr. Hofmann was recovering from knee surgery. The following are excerpts from their conversation.
Read on maps.org
CLEAR ALL
Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.
2
Frankl’s thesis echoes those of many sages, from Buddhists to Stoics to his 20th century Existentialist contemporaries: “Everything can be taken from a man but one thing: the last of the human freedoms—to choose one’s attitude in any given set of circumstances, to choose one’s own way.”
3
The exuberant “renaissance” of studies researching psychedelic-assisted psychotherapy in the past twenty years has not sufficiently included the enrollment of racially diverse participants, a problem that psychedelic science and clinical research shares with mainstream psychiatry
Amazonian healing traditions collide with Western medical sensibilities.
A new review of studies finds that LSD, psilocybin, and MDMA hold potential for treating mental illness.
1
I believe that the ability to discover deeper meaning in our lives is positively correlated with the amount of time we choose to spend in nature.
Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.
Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.
The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.
The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.